Isobel Finnie

Isobel leads the life sciences and biotechnology team at Haseltine Lake Kempner, Isobel is a highly knowledgeable patent practitioner and patent strategist who has circa 20 years of experience. She was a partner at an Am Law 100 firm immediately prior to joining Haseltine Lake Kempner, as well as having worked with other leading patent and trademark firms in London, which means clients value her analysis and input. She uses a collaborative approach to develop and implement IP strategies to support commercial requirements. Her strategic advice includes patent portfolio review, IP audits, IP due diligence, competitor IP analysis and freedom to operate (FTO) reviews, supplementary protection certificate (SPC) counseling, and the preparation of patent attorney reports for IPOs. In addition, her practice involves patent drafting and international patent prosecution, working with complex patent portfolios of interrelated cases before the European Patent Office and post-grant opposition and appeal proceedings.

In the healthcare space, she has developed considerable technical and professional expertise in the fields of cancer therapeutics and cancer pro-drugs, dermatology, biomarkers, diagnostics, vaccines, diabetes therapeutics, immunology, antibody-based therapeutics, stem cell technologies, DNA sequencing technologies, and medical devices.